A multi-site telemedicine initiative successfully delivered buprenorphine treatment to hundreds of individuals with opioid use disorder across six rural county jails, according to a retrospective observational study. Conducted between June 2020 and May 2025, the University of Maryland program demonstrated that virtual clinical care can overcome severe local provider shortages and logistical obstacles in underserved correctional facilities.
The persistent opioid overdose epidemic in the United States disproportionately impacts incarcerated populations, who experience a severely elevated risk of fatal overdose immediately following release. While administering medications for opioid use disorder in jail settings significantly curbs post-release mortality and fosters subsequent community treatment engagement, rural carceral facilities frequently lack the medical workforce required to provide on-site addiction pharmacotherapy during these critical short-term stays.
To evaluate the reach, implementation, and scalability of the remote intervention, researchers examined jail files and electronic health records covering 842 unique patients across 1,321 distinct treatment episodes. The analyzed cohort was predominantly male at 71.1 percent and White at 75.7 percent, with an average participant age of 35.4 years. Individuals in the study presented with high-severity substance use, reporting a mean duration of 12.6 years of opioid use.
Operating under broad admission criteria, the program prioritized both new treatment initiation and the continuation of existing care. Notably, 55.2 percent of participants were new initiates who were not receiving medications for opioid use disorder prior to their booking into the facility. Enrolled patients spent an average of 35.6 days in custody before their buprenorphine treatment was initiated through the telemedicine service.
Once enrolled, individuals remained in the tele-buprenorphine program for an average retention period of 66 days. Medical providers adjusted dosing over time, titrating buprenorphine from a mean starting dose of 8.8 milligrams to an average of 16.2 milligrams at the time of discharge. Among the patients who were retained in the program, clinical adherence reached 99.5 percent.
Concerns regarding institutional medication diversion or hoarding resulted in formal program discharge for only 3 percent of the entire sample. The authors concluded that telemedicine offers a feasible and scalable model to bridge critical addiction treatment disparities in rural jails, noting that liberal admission policies can reach high-risk individuals and potentially lower fatal overdose risks during the precarious transition back to the community.
Rural facilities frequently face significant logistical hurdles when attempting to establish on-site addiction treatment, particularly due to widespread provider shortages that complicate the delivery of standard substance use care. By implementing a multi-site tele-buprenorphine initiative, the University of Maryland program sought to mitigate these structural disparities. This model acknowledges that short-term carceral stays serve as a critical window for intervention, given that the period immediately following release is associated with a high risk of fatal overdose. Because community-based resources for opioid use disorder are often insufficient in rural jurisdictions, the research highlights how digital infrastructure can effectively bypass regional deficits in clinical staffing to deliver standardized pharmacotherapy.
The study design relied on a retrospective chart review, utilizing a dual-data approach that synthesized information from jail-based records and electronic health records. This methodology allowed for a robust longitudinal assessment of clinical patterns across six distinct rural county jails over a five-year period. By tracking patients from the point of booking through their time in custody, the researchers were able to quantify the scalability of the intervention. The findings suggest that when programs adopt broad admission criteria, they can successfully engage a population characterized by long-standing substance use, with participants in this cohort reporting an average of over a decade of opioid involvement. This scope underscores the program’s utility in reaching vulnerable individuals who might otherwise be disconnected from the healthcare system during their time of incarceration. By maintaining rigorous clinical oversight through virtual consultations, the model demonstrates that secure, scalable addiction treatment is achievable in resource-limited carceral environments, offering a potential path forward for addressing the broader epidemic of opioid-related mortality in underserved regions.
Subject of Research: Telemedicine buprenorphine treatment for opioid use disorder in rural jails
Article Title: Telemedicine-based buprenorphine initiation and maintenance in rural jails: a retrospective observational study
Article References: Belcher, A. M., O’Rourke, A., C. Smith, H., Fitzsimons, H., Ruelas-Vargas, K., Welsh, C. J., Saloner, B. K., & Weintraub, E. (2026). Telemedicine-based buprenorphine initiation and maintenance in rural jails: a retrospective observational study. Health & Justice. https://doi.org/10.1186/s40352-026-00451-y
Image Credits: AI Generated
DOI: 10.1186/s40352-026-00451-y
Keywords: telemedicine, buprenorphine, opioid use disorder, rural jails, carceral health, medications for opioid use disorder, treatment retention, dose titration, medication adherence, post-release overdose prevention, retrospective chart review, University of Maryland, electronic health records, treatment initiation, medication diversion, county correctional facilities, incarcerated populations
News Source: Ophelia Keating. (November 18, 2026). Rural Jails Successfully Deliver Buprenorphine Treatment Using Telemedicine Program. Scienmag.



